BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2286784)

  • 1. [Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole].
    Shikiya K; Kuniyoshi T; Higashionna A; Arakkaki T; Oyakawa T; Kadena K; Kinjo F; Saito A; Asato R
    Kansenshogaku Zasshi; 1990 Nov; 64(11):1408-15. PubMed ID: 2286784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New trial with thiabendazole for treatment of human strongyloidiasis].
    Oyakawa T; Kuniyoshi T; Arakaki T; Higashionna A; Shikiya K; Sakugawa H; Kadena K; Kitsukawa K; Kinjo F; Saito A
    Kansenshogaku Zasshi; 1991 Mar; 65(3):304-10. PubMed ID: 2071949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of strongyloidiasis with mebendazole--long-term eradication and new trials].
    Shikiya K; Kuniyoshi T; Uechi H; Oyakawa T; Kinjo F; Saito A; Ikema M; Nakamura H; Yamashiro M; Asato R
    Kansenshogaku Zasshi; 1991 Apr; 65(4):433-41. PubMed ID: 2071960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice.
    Grove DI
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):469-76. PubMed ID: 7081540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term eradication rate of mebendazole therapy for strongyloidiasis].
    Shikiya K; Zaha O; Niimura S; Ikema M; Nakamura H; Nakayoshi T; Uechi H; Kinjo F; Saito A; Ohwan T
    Kansenshogaku Zasshi; 1992 Mar; 66(3):354-9. PubMed ID: 1624824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Strongyloides stercoralis in a blind loop of the bowel. Successful treatment with mebendazole.
    Wilson KH; Kauffman CA
    Arch Intern Med; 1983 Feb; 143(2):357-8. PubMed ID: 6824404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of thiabendazole and mebendazole in strongyloidiasis].
    Beus A
    Lijec Vjesn; 1989 Mar; 111(3):98-101. PubMed ID: 2747412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on symptoms in patients with strongyloidiasis].
    Zaha O; Niimura S; Kinjo N; Ikema M; Nakamura H; Uehara T; Uechi H; Ohshiro J; Shikiya K; Kinjo F
    Kansenshogaku Zasshi; 1992 Oct; 66(10):1378-82. PubMed ID: 1293217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strongyloides ratti and S. stercoralis: effects of cambendazole, thiabendazole and mebendazole in vitro.
    Grove DI; Northern C
    Rev Inst Med Trop Sao Paulo; 1986; 28(2):97-103. PubMed ID: 3797953
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of ivermectin against Strongyloides stercoralis in humans.
    Shikiya K; Kinjo N; Uehara T; Uechi H; Ohshiro J; Arakaki T; Kinjo F; Saito A; Iju M; Kobari K
    Intern Med; 1992 Mar; 31(3):310-2. PubMed ID: 1611180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis.
    Grove DI; Northern C
    Trans R Soc Trop Med Hyg; 1988; 82(1):146-9. PubMed ID: 3176142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis].
    Shikiya K; Kinjo N; Ikema M; Yamashiro A; Uechi H; Oyakawa T; Kinjo F; Saito A; Nakamura H; Ohwan T
    Kansenshogaku Zasshi; 1991 Jun; 65(6):681-6. PubMed ID: 1919097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum.
    Boken DJ; Leoni PA; Preheim LC
    Clin Infect Dis; 1993 Jan; 16(1):123-6. PubMed ID: 8448287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of disseminated strongyloidiasis.
    Coulter C; Walker DG; Günsberg M; Brown IG; Bligh JF; Prociv P
    Med J Aust; 1992 Sep; 157(5):331-2. PubMed ID: 1435478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thiabendazole against Strongyloides infection in foals].
    Hiepe T; Siebeke F; Nickel S
    Angew Parasitol; 1971 May; 12(2):65-7. PubMed ID: 5153507
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness.
    Grove DI
    Trans R Soc Trop Med Hyg; 1982; 76(1):114-8. PubMed ID: 7080143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strongyloides stercoarlis--hyperinfection.
    Boyd WP; Campbell FW; Trudeau WL
    Am J Trop Med Hyg; 1978 Jan; 27(1 Pt 1):39-41. PubMed ID: 626279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent strongyloidiasis in an immunodeficient patient.
    Shelhamer JH; Neva FA; Finn DR
    Am J Trop Med Hyg; 1982 Jul; 31(4):746-51. PubMed ID: 7102907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic strongyloidiasis in Tasmanian veterans--clinical diagnosis by the use of a screening index.
    Oliver NW; Rowbottom DJ; Sexton P; Goldsmid JM; Byard R; Tooth M; Thomson KS
    Aust N Z J Med; 1989 Oct; 19(5):458-62. PubMed ID: 2590096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis.
    Pitisuttithum P; Supanaranond W; Chindanond D
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):735-8. PubMed ID: 9139386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.